Showing Results for
From:Pharmaceutical Technology (Vol. 34, Issue 11) Peer-ReviewedPatent applicants seem to be facing a conflicting approval environment in India. The Delhi High Court recently turned down a plea by Bristol-Myers Squibb (BMS, New York) to stop Ranbaxy Laboratories (Gurgaon, Haryana)...
From:Pharmaceutical Technology Europe (Vol. 25, Issue 5) Peer-ReviewedSolid-form characterisation and research are important for improving the understanding of and modification of the physical properties of APIs to ensure therapeutic benefit, optimise product development and protect...
From:Pharmaceutical Technology (Vol. 37, Issue 5) Peer-ReviewedThe rejection by India's Supreme Court on Novartis' Glivec/Gleevec (imatinib mesylate) and other recent case law raise important issues on patent strategies for solid forms. Solid-form characterization and research...
Choose how you want to be alerted when new results for your search become available.
Subscribe to Gale's RSS feed to get content delivered to your favorite RSS aggregator. Copy and paste the URL below into your reader:
Tell us where to send the alert and how often you want to receive it